» Articles » PMID: 35096672

Association of Specific Haplotype of Tumor Necrosis Factor-α and Interleukin-1β Polymorphisms with Infection and Gastric Carcinogenesis

Overview
Journal Germs
Date 2022 Jan 31
PMID 35096672
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The infection and cytokine-mediated inflammatory responses play significant roles in the pathogenesis of gastric cancer (GC). This study was performed to determine the association between the risk of GC and genetic polymorphisms in interleukin (IL)-1β and tumor necrosis factor-alpha (TNF-α).

Methods: The polymorphisms of IL-1β and TNF-α genes were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 290 patients who underwent endoscopy. Infection with was diagnosed by histological analysis, rapid urease test, and PCR of gastric biopsy samples. Quantitative real-time PCR was performed to determine the relative mRNA expression levels.

Results: No significant difference was detected in allele frequency and genotype of all studied polymorphisms between chronic gastritis (CG), GC and healthy individuals. IL-1β mRNA was down-regulated in both gastritis (relative quantification (RQ)=0.447) and the GC groups (RQ=0.151). In contrast, the expression of TNF-α was up-regulated in the GC group (RQ=2.817) compared to the gastritis group (RQ=0.861).

Conclusions: The studied single-nucleotide polymorphisms are not risk factors for development of CG and GC. However, infection causes a huge increase in the TNF-α expression in GC patients.

References
1.
Ma J, Wu D, Hu X, Li J, Cao M, Dong W . Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis. PLoS One. 2017; 12(4):e0176463. PMC: 5409176. DOI: 10.1371/journal.pone.0176463. View

2.
Liou J, Malfertheiner P, Lee Y, Sheu B, Sugano K, Cheng H . Screening and eradication of for gastric cancer prevention: the Taipei global consensus. Gut. 2020; 69(12):2093-2112. DOI: 10.1136/gutjnl-2020-322368. View

3.
Ishaq S, Nunn L . Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench. 2015; 8(Suppl 1):S6-S14. PMC: 4495426. View

4.
Sugimoto M, Furuta T, Shirai N, Ikuma M, Hishida A, Ishizaki T . Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy. Clin Pharmacol Ther. 2006; 80(1):41-50. DOI: 10.1016/j.clpt.2006.03.007. View

5.
Hishida A, Matsuo K, Goto Y, Hamajima N . Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World J Gastrointest Oncol. 2010; 2(10):369-79. PMC: 2999673. DOI: 10.4251/wjgo.v2.i10.369. View